U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H27N7O3
Molecular Weight 473.527
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EMD-1204831 FREE BASE

SMILES

CN1C=C(C=N1)C2=NN(CC3=CC=CC(=C3)C4=NC=C(OCCN5CCOCC5)C=N4)C(=O)C=C2

InChI

InChIKey=CIUKPBWULKEZMF-UHFFFAOYSA-N
InChI=1S/C25H27N7O3/c1-30-18-21(14-28-30)23-5-6-24(33)32(29-23)17-19-3-2-4-20(13-19)25-26-15-22(16-27-25)35-12-9-31-7-10-34-11-8-31/h2-6,13-16,18H,7-12,17H2,1H3

HIDE SMILES / InChI

Molecular Formula C25H27N7O3
Molecular Weight 473.527
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors.
2013 Jun 1
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 03:01:48 GMT 2023
Edited
by admin
on Sat Dec 16 03:01:48 GMT 2023
Record UNII
GVM730CHWW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EMD-1204831 FREE BASE
Code English
4-(2-(2-(3-(3-(1-METHYL-1HPYRAZOL-4-YL)-6-OXO-1,6-DIHYDROPYRIDAZIN-1-YLMETHYL)-PHENYL)-PYRIMIDIN-5-YLOXY)-ETHYL)-MORPHOLINE)
Systematic Name English
Code System Code Type Description
CAS
1100598-15-9
Created by admin on Sat Dec 16 03:01:48 GMT 2023 , Edited by admin on Sat Dec 16 03:01:48 GMT 2023
PRIMARY
FDA UNII
GVM730CHWW
Created by admin on Sat Dec 16 03:01:48 GMT 2023 , Edited by admin on Sat Dec 16 03:01:48 GMT 2023
PRIMARY
SMS_ID
100000175768
Created by admin on Sat Dec 16 03:01:48 GMT 2023 , Edited by admin on Sat Dec 16 03:01:48 GMT 2023
PRIMARY
PUBCHEM
25134692
Created by admin on Sat Dec 16 03:01:48 GMT 2023 , Edited by admin on Sat Dec 16 03:01:48 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY